News
Archive
Emporos and InterLink AI Partner, develop only POS-Integrated lighted will-call solution
Phase Four partners with Redwire to expand space propulsion offerings and deliver Hall Effect Thrusters
Ventyx Biosciences announces positive preclinical data for CNS-penetrant NLRP3 inhibitor VTX3232 demonstrating reversal of obesity and improvements in cardiometabolic and inflammatory markers
Resolve Therapeutics publishes results of RSLV-132 Phase 2 long COVID study
Finally, Graphene electronic devices available for all
DARPA awards Phase Four $14.9M contract to develop Air Breathing Electric Propulsion for Very Low Earth Orbit operations
Back To News![TherOx Receives FDA Approval for the First Heart Attack Treatment Since PCI to Reduce Infarct Size](https://www.newscienceventures.com/wp-content/uploads/2020/11/cropped-TherOx_RGB_600x200.png)
April 4, 2019